We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

129 hedge funds and large institutions have $522M invested in Amphastar Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $489M → $522M (+$33.5M)

0.4% less ownership

Funds ownership: 55.13% → 54.73% (-0.4%)

5% less funds holding

Funds holding: 136 → 129 (-7)

21% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 53

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
129
Holders Change
-7
Holders Change %
-5.15%
% of All Funds
2.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
42
Reduced
53
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$9.45M
2
BlackRock
BlackRock
New York
+$4.69M
3
Morgan Stanley
Morgan Stanley
New York
+$4.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.33M
5
Prudential Financial
Prudential Financial
New Jersey
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$5.28M
2
Two Sigma Investments
Two Sigma Investments
New York
-$3.54M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$2.36M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$2.25M
5
AL
AJO LP
Pennsylvania
-$2.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
MOACM
101
Mutual of America Capital Management
New York
$92K +$3.29K +169 +4%
VCG
102
Vantage Consulting Group
Virginia
$71K +$68.7K +3,532 New
AIP
103
Ameritas Investment Partners
Nebraska
$62K – – –
Lazard Asset Management
104
Lazard Asset Management
New York
$57K +$7.88K +405 +16%
PNC Financial Services Group
105
PNC Financial Services Group
Pennsylvania
$48K +$5.27K +271 +13%
US Bancorp
106
US Bancorp
Minnesota
$24K – – –
TRCT
107
Tower Research Capital (TRC)
New York
$21K -$255K -13,125 -93%
PCM
108
Penserra Capital Management
California
$21K +$13.3K +686 +170%
PFPT
109
Pinnacle Financial Partners (Tennessee)
Tennessee
$19K – – –
Macquarie Group
110
Macquarie Group
Australia
$13K – – –
FQ
111
First Quadrant
California
$11K +$1.89K +97 +21%
SWA
112
Sutton Wealth Advisors
Florida
$9.81K – – –
VCM
113
Versant Capital Management
Arizona
$9K – – –
S
114
SignatureFD
Georgia
$9K +$992 +51 +13%
QT
115
Quantbot Technologies
New York
$6K +$5.84K +300 New
PWPS
116
Pinnacle Wealth Planning Services
Ohio
$5K +$4.48K +230 New
KFS
117
Kelly Financial Services
Massachusetts
$3.02K – – –
Daiwa Securities Group
118
Daiwa Securities Group
Japan
$2K -$3.42K -176 -66%
MAM
119
Meeder Asset Management
Ohio
$2K -$623 -32 -23%
ABC
120
Associated Banc-Corp
Wisconsin
$2K – – –
TFO
121
Tarbox Family Office
California
$2K – – –
CAPTRUST Financial Advisors
122
CAPTRUST Financial Advisors
North Carolina
$2K +$1.46K +75 New
Osaic Holdings
123
Osaic Holdings
Arizona
$1K -$8.66K -445 -91%
ACM
124
AUA Capital Management
Pennsylvania
$1K -$448 -23 -36%
LC
125
Lindbrook Capital
California
$1K – – –
2 3 4
5
6

AMPH Hedge Fund Activity: Q4 2020 in Review

129 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q4 2020, worth a combined $522M — up 6.9% from $489M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AMPH and 9 opened new positions — a net loss of 7 holders — while 53 trimmed existing stakes and 42 added.

The largest buyer was Federated Hermes, adding an estimated $9.45M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $5.28M.

  • 129 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q4 2020, down from 136 in Q3 2020.
  • Funds reported $522M of Amphastar Pharmaceuticals stock for Q4 2020, up 6.9% quarter-over-quarter.
  • 9 funds opened new Amphastar Pharmaceuticals positions in Q4 2020 and 16 closed out, a net change of -7 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q4 2020 was Federated Hermes, an estimated $9.45M added.
  • The largest Amphastar Pharmaceuticals seller in Q4 2020 was Fuller & Thaler Asset Management, an estimated $5.28M sold.

Based on aggregated 13F filings for Q4 2020.